Background: Beginning in 1994, Vancouver experienced an explosive outbreak of HIV
infection among injection drug users (IDUs). The objectives of this study were to measure …

We used data and leftover samples collected through the SurvUDI network to describe the
epidemiology of hepatitis C virus (HCV) infection among injection drug users (IDUs) in …

Objective: To assess trends in HIV, hepatitis C virus (HCV) and HIV/HCV infection among
injecting drug users (IDU) from 1990 to 2001 in New York City. The 1990–2001 time period …

Injecting drug users (DU) are at high risk for hepatitis C virus (HCV) and HIV infections. To
examine the prevalence and incidence of these infections over a 20-year period (1985 …

Objective. To examine hepatitis C virus (HCV) seroprevalence among injection drug users in
4 US cities from 1994 through 2004. Methods. Demographic characteristics, behaviors, and …

Studies of HIV-positive patients have consistently shown that drug users, in particular
injection drug users (IDU), are far more likely to have hepatitis C virus (HCV) infection than …

OBJECTIVE--To study risk factors for hepatitis C virus (HCV) infection in injecting drug users
(IDUs) from central Sydney. SETTING AND SUBJECTS--All IDUs attending a primary health …

Objectives: To determine the prevalence of HCV antibodies among injecting drug users and
to gauge the effectiveness of needle/syringe exchange in preventing the transmission of …

Between 1988 and 1996, the incidence of and risk factors for hepatitis C virus (HCV)
infection were studied in a cohort of injection drug users in Baltimore, Maryland. By second …

In order to evaluate the incidence and risk factors of infection by hepatitis C virus (HCV)
among injecting drug users (IDUs), we conducted a prospective cohort study of HCV-and …